Sherese Fralin

539 total citations
11 papers, 403 citations indexed

About

Sherese Fralin is a scholar working on Genetics, Biomedical Engineering and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sherese Fralin has authored 11 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 8 papers in Biomedical Engineering and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sherese Fralin's work include Glioma Diagnosis and Treatment (11 papers), Nanoplatforms for cancer theranostics (8 papers) and Brain Metastases and Treatment (7 papers). Sherese Fralin is often cited by papers focused on Glioma Diagnosis and Treatment (11 papers), Nanoplatforms for cancer theranostics (8 papers) and Brain Metastases and Treatment (7 papers). Sherese Fralin collaborates with scholars based in United States and Switzerland. Sherese Fralin's co-authors include John A. Boockvar, Apostolos John Tsiouris, Howard A. Riina, Jared Knopman, David J. Langer, Ronald Scheff, Rafael Ortiz, Christopher G. Filippi, Shamik Chakraborty and Stephen Seedial and has published in prestigious journals such as Journal of neurosurgery, Journal of Neuro-Oncology and World Neurosurgery.

In The Last Decade

Sherese Fralin

11 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sherese Fralin United States 9 254 152 96 90 82 11 403
Ya-Jui Lin Taiwan 11 148 0.6× 224 1.5× 51 0.5× 91 1.0× 26 0.3× 27 521
W. Ullrich Germany 5 330 1.3× 268 1.8× 156 1.6× 51 0.6× 83 1.0× 9 521
Sylvia C. Kurz United States 12 199 0.8× 105 0.7× 125 1.3× 148 1.6× 22 0.3× 33 538
Marek Mazurek Poland 12 172 0.7× 79 0.5× 111 1.2× 230 2.6× 21 0.3× 28 592
Zhiping Zhou United States 12 326 1.3× 96 0.6× 73 0.8× 141 1.6× 59 0.7× 28 671
Christina Jackson United States 14 393 1.5× 76 0.5× 103 1.1× 133 1.5× 26 0.3× 29 708
Lina Marenco-Hillembrand United States 9 200 0.8× 54 0.4× 64 0.7× 80 0.9× 18 0.2× 24 390
Saira Alli Canada 6 105 0.4× 127 0.8× 23 0.2× 56 0.6× 29 0.4× 9 308
Leslie D. McAllister United States 7 451 1.8× 119 0.8× 190 2.0× 82 0.9× 58 0.7× 9 714
Kathleen McCortney United States 10 136 0.5× 52 0.3× 38 0.4× 136 1.5× 29 0.4× 21 333

Countries citing papers authored by Sherese Fralin

Since Specialization
Citations

This map shows the geographic impact of Sherese Fralin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherese Fralin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherese Fralin more than expected).

Fields of papers citing papers by Sherese Fralin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherese Fralin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherese Fralin. The network helps show where Sherese Fralin may publish in the future.

Co-authorship network of co-authors of Sherese Fralin

This figure shows the co-authorship network connecting the top 25 collaborators of Sherese Fralin. A scholar is included among the top collaborators of Sherese Fralin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherese Fralin. Sherese Fralin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Patel, Nitesh V., Sherese Fralin, Randy S. D’Amico, et al.. (2021). Repeated superselective intraarterial bevacizumab after blood brain barrier disruption for newly diagnosed glioblastoma: a phase I/II clinical trial. Journal of Neuro-Oncology. 155(2). 117–124. 16 indexed citations
2.
D’Amico, Randy S., Deepak Khatri, Nitesh V. Patel, et al.. (2020). Super selective intra-arterial cerebral infusion of modern chemotherapeutics after blood–brain barrier disruption: where are we now, and where we are going. Journal of Neuro-Oncology. 147(2). 261–278. 59 indexed citations
3.
Patel, Nitesh V., Deepak Khatri, Randy S. D’Amico, et al.. (2020). Vascularized Temporoparietal Fascial Flap: A Novel Surgical Technique to Bypass the Blood-Brain Barrier in Glioblastoma. World Neurosurgery. 143. 38–45. 8 indexed citations
4.
Khatri, Deepak, Nitesh V. Patel, Randy S. D’Amico, et al.. (2020). Update on glioma biotechnology. Clinical Neurology and Neurosurgery. 195. 106075–106075. 4 indexed citations
5.
Patel, Nitesh V., Sherese Fralin, Christopher G. Filippi, et al.. (2019). Rechallenging Recurrent Glioblastoma with Intra-Arterial Bevacizumab with Blood Brain–Barrier Disruption Results in Radiographic Response. World Neurosurgery. 131. 234–241. 11 indexed citations
6.
Schneider, Julia, Shamik Chakraborty, Christopher G. Filippi, et al.. (2018). Superselective intraarterial cerebral infusion of cetuximab with blood brain barrier disruption combined with Stupp Protocol for newly diagnosed glioblastoma.. PubMed. 12(3). 223–229. 5 indexed citations
7.
Chakraborty, Shamik, Christopher G. Filippi, Sherese Fralin, et al.. (2016). Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study. Journal of Neuro-Oncology. 128(3). 405–415. 79 indexed citations
8.
Chakraborty, Shamik, Christopher G. Filippi, Jan‐Karl Burkhardt, et al.. (2016). Durability of single dose intra-arterial bevacizumab after blood/brain barrier disruption for recurrent glioblastoma.. PubMed. 11(4). 261–267. 22 indexed citations
9.
Riina, Howard A., Jared Knopman, Jeffrey P. Greenfield, et al.. (2010). Balloon-Assisted Superselective Intra-Arterial Cerebral Infusion of Bevacizumab for Malignant Brainstem Glioma. Interventional Neuroradiology. 16(1). 71–76. 37 indexed citations
10.
Boockvar, John A., Apostolos John Tsiouris, Christoph P. Hofstetter, et al.. (2010). Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Journal of neurosurgery. 114(3). 624–632. 123 indexed citations
11.
Riina, Howard A., Justin F. Fraser, Sherese Fralin, et al.. (2009). Superselective intraarterial cerebral infusion of bevacizumab: a revival of interventional neuro-oncology for malignant glioma.. PubMed. 8(2). 145–50. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ya-Jui Lin Breakdown of academic impact, for papers by W. Ullrich Breakdown of academic impact, for papers by Sylvia C. Kurz Breakdown of academic impact, for papers by Marek Mazurek Breakdown of academic impact, for papers by Zhiping Zhou Breakdown of academic impact, for papers by Christina Jackson Breakdown of academic impact, for papers by Lina Marenco-Hillembrand Breakdown of academic impact, for papers by Saira Alli Breakdown of academic impact, for papers by Leslie D. McAllister Breakdown of academic impact, for papers by Kathleen McCortney
Rankless by CCL
2026